世界の医療用大麻の市場規模は、2027年末までに332億1,021万米ドルを超え、18.14%の大幅なCAGRで成長すると予想されています。医療用大麻は、有効な治療効果があります。この植物の最も良い点は、さまざまな薬用協会によって未精製の材料として使用され、さまざまな医薬品用途の薬を製造していることです。 臨床上の理由からの大麻の真の使用法は、その説得力のある利点のために拡大しています。いずれにせよ、それはその使用のための動き、所有権、進歩、および臨床仕上げの事務処理のために国を越えてシフトします。医療用大麻市場のもう1つの推進力は、継続的な汚染とさまざまな病気の蔓延です。臨床大麻は、成人の容赦ない感染によって達成される休息の問題、圧力、苦痛などの追加の兆候を生み出すために保証され、驚くべきものです。
同市場の拡大は、大麻の使用量の増加、進行性疾患の有病率の上昇など、さまざまな要素によって推進されています。各国で医療用大麻の合法化が高まっていることで、カンナビノイドの研究と改良が進んでいます。しかしながら、マリファナの違法使用の増加が、市場全体の見通しを悪化させることが予想されます。臨床ビジネスにおける大麻の様々な採用があり、これが医療用大麻市場の発展を促進しています。この10年、大麻の使用は様々な物質と乖離し、さらに即座に拡張しています。大麻の使用は急速に進んでおり、西ヨーロッパ、北アメリカ、オーストラリアなどの先進国では、単に上昇しています。
種に基づいて、市場は大麻インディカ、サティバ、および交雑種に分けられます。派生物セグメントによって、市場はカンナビジオール（CBD）、テトラヒドロカンナビノール（THC）などに分類されています。用途の面では、市場は主な分類に対処する病気に分けられています。エンドユースによって、市場は医薬品ビジネス、革新的なワークコミュニティなどに分類されています。 投与経路に応じて、市場は経口、喫煙、吸入、局所（外用）などに分けられています。
南北アメリカは、臨床大麻の消費量の増加と一人当たりの臨床考察利用率の上昇から、最大の市場であると推測されます。南北アメリカの市場はさらに北アメリカとラテンアメリカに分割されており、北アメリカ市場はアメリカとカナダに分かれています。ヨーロッパの医療用大麻市場は、西ヨーロッパと東ヨーロッパに分けられます。
本レポートは、COVID-19の大流行があらゆる領域の様々な産業や業種に与える影響を継続的に追跡しています。当社の調査レポートには、COVID-19が各産業に与える影響による低下と上昇を理解するのに役立つ情報が記載されています。また、関心のある市場の需要と供給のギャップを特定するのに役立ちます。さらに、このレポートは、分析、政府規制の修正、およびその他の多くの有用な洞察に役立ちます。
目次
TABLE OF CONTENTS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING R&D ACTIVITIES AND FINANCIAL SUPPORT BY VARIOUS PRIVATE AND GOVERNMENT ORGANIZATIONS
4.2.2 RISING OCCURRENCE OF CHRONIC DISEASES AND OTHER MEDICAL CONDITIONS
4.2.3 LEGALIZATION OF MEDICAL CANNABIS IN VARIOUS REGIONS
4.3 RESTRAINTS
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS
4.3.2 STRINGENT GOVERNMENT POLICIES RELATED TO CBD OIL
4.4 OPPORTUNITIES
4.4.1 IMPROVING STATUS OF CANNABIS IN ASIAN AND AFRICAN COUNTRIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 PROCUREMENT OF RAW MATERIALS
5.1.2 R&D
5.1.3 MANUFACTURING
5.1.4 DISTRIBUTION AND SALES
5.1.5 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE MEDICAL CANNABIS MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON DEMAND FOR MEDICAL CANNABIS
5.3.4 IMPACT ON EXISTING REGULATIONS
5.3.5 IMPACT ON RESEARCH
5.3.6 IMPACT ON BUYERS AND SUPPLIERS
6 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SOLIDS
6.3 DISSOLVABLES/POWDERS
6.4 OIL
6.5 OINTMENTS & CREAMS
7 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE
7.1 OVERVIEW
7.2 CANNABIDIOL
7.3 TETRAHYDROCANNABINOL
8 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW
8.2 INHALATION
8.3 ORAL
8.4 TOPICAL
9 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 PAIN MANAGEMENT
9.2.1 NEUROPATHIC PAIN
9.2.2 CANCER
9.2.3 INFLAMMATORY PAIN
9.3 NEUROLOGICAL HEALTH MANAGEMENT
9.3.1 SCLEROSIS
9.3.2 EPILEPSY
9.3.3 ALZHEIMER'S DISEASE
9.3.4 PARKINSON'S DISEASE
9.3.5 OTHERS
9.4 MENTAL HEALTH MANAGEMENT
9.4.1 POST-TRAUMATIC STRESS DISORDER (PTSD)
9.4.2 DEPRESSION
9.4.3 ANXIETY
9.4.4 OTHERS
10 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 HOSPITAL PHARMACY
10.3 RETAIL PHARMACY
10.4 ONLINE PHARMACY
11 GLOBAL MEDICAL CANNABIS MARKET, BY REGION
11.1 OVERVIEW
11.2 AMERICAS
11.2.1 NORTH AMERICA
11.2.1.1 US
11.2.1.2 CANADA
11.2.2 LATIN AMERICA
11.3 EUROPE
11.3.1 WESTERN EUROPE
11.3.1.1 GERMANY
11.3.1.2 FRANCE
11.3.1.3 UK
11.3.1.4 ITALY
11.3.1.5 SPAIN
11.3.1.6 REST OF WESTERN EUROPE
11.3.2 EASTERN EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 AUSTRALIA
11.4.3 SOUTH KOREA
11.4.4 REST OF ASIA-PACIFIC
11.5 MIDDLE EAST & AFRICA
11.5.1 MIDDLE EAST
11.5.2 AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL CANNABIS MARKET
12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL CANNABIS MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
12.6.2 MERGER/ACQUISITION
12.6.3 PARTNERSHIP/AGREEMENT
12.6.4 EXPANSION
13 COMPANY PROFILES
13.1 CANOPY GROWTH CORPORATION
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS/SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 CANNABIS SATIVA, INC.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS/SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 GW PHARMACEUTICALS PLC
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS/SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 EMERALD HEALTH THERAPEUTICS
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS/SERVICES OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 SWOT ANALYSIS
13.4.6 KEY STRATEGIES
13.5 TILRAY, INC.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCT OFFERINGS
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 AURORA CANNABIS INC.
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS/SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 CARA THERAPEUTICS
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS/SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 MEDICAL MARIJUANA, INC.
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS/SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGIES
13.9 GB SCIENCES, INC.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS/SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 CANNDOC
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS/SERVICES OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 SWOT ANALYSIS
13.10.6 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 LEGALITY OF MEDICAL CANNABIS, BY REGION:
TABLE 4 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 5 GLOBAL MEDICAL CANNABIS MARKET, FOR SOLIDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 GLOBAL MEDICAL CANNABIS MARKET, FOR DISSOLVABLES/POWDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 7 GLOBAL MEDICAL CANNABIS MARKET, FOR OIL, BY REGION, 2018-2027 (USD MILLION)
TABLE 8 GLOBAL MEDICAL CANNABIS MARKET, FOR OINTMENTS & CREAMS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 10 GLOBAL MEDICAL CANNABIS MARKET FOR CANNABIDIOL, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 GLOBAL MEDICAL CANNABIS MARKET, FOR TETRAHYDROCANNABINOL, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 13 GLOBAL MEDICAL CANNABIS MARKET FOR INHALATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 14 GLOBAL MEDICAL CANNABIS MARKET, FOR ORAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 GLOBAL MEDICAL CANNABIS MARKET, FOR TOPICAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 16 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 17 GLOBAL MEDICAL CANNABIS MARKET FOR PAIN MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 GLOBAL MEDICAL CANNABIS MARKET FOR PAIN MANAGEMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 19 GLOBAL MEDICAL CANNABIS MARKET FOR NEUROPATHIC PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 GLOBAL MEDICAL CANNABIS MARKET FOR CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 21 GLOBAL MEDICAL CANNABIS MARKET FOR INFLAMMATORY PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 GLOBAL MEDICAL CANNABIS MARKET, FOR NEUROLOGICAL HEALTH MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 GLOBAL MEDICAL CANNABIS MARKET, FOR NEUROLOGICAL HEALTH MANAGEMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 24 GLOBAL MEDICAL CANNABIS MARKET FOR SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 GLOBAL MEDICAL CANNABIS MARKET FOR EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 GLOBAL MEDICAL CANNABIS MARKET FOR ALZHEIMER'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 27 GLOBAL MEDICAL CANNABIS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 GLOBAL MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 GLOBAL MEDICAL CANNABIS MARKET, FOR MENTAL HEALTH MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 GLOBAL MEDICAL CANNABIS MARKET, FOR MENTAL HEALTH MANAGEMENT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 31 GLOBAL MEDICAL CANNABIS MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018-2027 (USD MILLION)
TABLE 32 GLOBAL MEDICAL CANNABIS MARKET FOR DEPRESSION, BY REGION, 2018-2027 (USD MILLION)
TABLE 33 GLOBAL MEDICAL CANNABIS MARKET FOR ANXIETY, BY REGION, 2018-2027 (USD MILLION)
TABLE 34 GLOBAL MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 35 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 36 GLOBAL MEDICAL CANNABIS MARKET FOR HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 37 GLOBAL MEDICAL CANNABIS MARKET, FOR RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 38 GLOBAL MEDICAL CANNABIS MARKET, FOR ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 39 GLOBAL MEDICAL CANNABIS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 40 AMERICAS: MEDICAL CANNABIS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 41 AMERICAS: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 42 AMERICAS: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 43 AMERICAS: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 44 AMERICAS: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 45 AMERICAS: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 46 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 48 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 49 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 50 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 51 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 52 US: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 53 US: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 54 US: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 55 US: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 56 US: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 57 CANADA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 58 CANADA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 59 CANADA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 60 CANADA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 61 CANADA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 62 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 63 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 64 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 65 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 66 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 67 EUROPE: MEDICAL CANNABIS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 68 EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 69 EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 70 EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 71 EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 72 EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 73 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 74 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 75 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 76 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 77 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 78 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 79 GERMANY: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 80 GERMANY: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 81 GERMANY: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 82 GERMANY: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 83 GERMANY: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 84 FRANCE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 85 FRANCE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 86 FRANCE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 87 FRANCE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 88 FRANCE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 89 UK: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 90 UK: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 91 UK: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 92 UK: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 93 UK: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 94 ITALY: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 95 ITALY: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 96 ITALY: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 97 ITALY: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 98 ITALY: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 99 SPAIN: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 100 SPAIN: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 101 SPAIN: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 102 SPAIN: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 103 SPAIN: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 104 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 105 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 106 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 107 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 108 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 109 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 110 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 111 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 112 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 113 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 114 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 115 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 116 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 117 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 118 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 119 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 120 JAPAN: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 121 JAPAN: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 122 JAPAN: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 123 JAPAN: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 124 JAPAN: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 125 AUSTRALIA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 126 AUSTRALIA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 127 AUSTRALIA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 128 AUSTRALIA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 129 AUSTRALIA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 130 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 131 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 132 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 133 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 134 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 135 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 136 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 137 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 138 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 139 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 146 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 147 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 148 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 149 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 150 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 151 AFRICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 152 AFRICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018-2027 (USD MILLION)
TABLE 153 AFRICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 154 AFRICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018-2027 ((USD MILLION)
TABLE 155 AFRICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 156 MAJOR PLAYERS IN THE GLOBAL MEDICAL CANNABIS MARKET
TABLE 157 MOST ACTIVE PLAYER IN THE GLOBAL MEDICAL CANNABIS MARKET
TABLE 158 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 159 MERGER/ACQUISITION
TABLE 160 PARTNERSHIP/AGREEMENT
TABLE 161 EXPANSION/ INVESTMENT
TABLE 162 CANOPY GROWTH CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 163 CANOPY GROWTH CORPORATION: KEY DEVELOPMENTS
TABLE 164 CANNABIS SATIVA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 165 CANNABIS SATIVA, INC.: KEY DEVELOPMENTS
TABLE 166 GW PHARMACEUTICALS PLC: PRODUCTS/SERVICES OFFERED
TABLE 167 GW PHARMACEUTICALS PLC: KEY DEVELOPMENTS
TABLE 168 EMERALD HEALTH THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 169 EMERALD HEALTH THERAPEUTICS: KEY DEVELOPMENTS
TABLE 170 TILRAY, INC.: PRODUCT OFFERINGS
TABLE 171 TILRAY, INC.: KEY DEVELOPMENTS
TABLE 172 AURORA CANNABIS INC.: PRODUCTS/SERVICES OFFERED
TABLE 173 AURORA CANNABIS INC.: KEY DEVELOPMENTS
TABLE 174 CARA THERAPEUTICS: PRODUCTS/SERVICES OFFERED
TABLE 175 CARA THERAPEUTICS: KEY DEVELOPMENTS
TABLE 176 MEDICAL MARIJUANA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 177 GB SCIENCES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 178 GB SCIENCES, INC.: KEY DEVELOPMENTS
TABLE 179 CANNDOC: PRODUCTS/SERVICES OFFERED
TABLE 180 CANNDOC: KEY DEVELOPMENTS ?
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET STRUCTURE: GLOBAL MEDICAL CANNABIS MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: MEDICAL CANNABIS MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: MEDICAL CANNABIS MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: MEDICAL CANNABIS MARKET
FIGURE 9 IMPACTS OF COVID-19 ON PURCHASING ABILITIES, CANADA, 2020
FIGURE 10 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION)
FIGURE 11 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2020 & 2027 (USD MILLION)
FIGURE 12 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2027 (USD MILLION)
FIGURE 13 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)
FIGURE 14 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION)
FIGURE 15 GLOBAL MEDICAL CANNABIS MARKET, BY REGION 2020 & 2027 (USD MILLION)
FIGURE 16 GLOBAL MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020
FIGURE 17 AMERICAS: MEDICAL CANNABIS MARKET SHARE, BY REGION 2020 (%)
FIGURE 18 NORTH AMERICA: MEDICAL CANNABIS MARKET SHARE, BY COUNTRY 2020 (%)
FIGURE 19 EUROPE: MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020
FIGURE 20 WESTERN EUROPE: MEDICAL CANNABIS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 21 ASIA-PACIFIC: MEDICAL CANNABIS MARKET SHARE (%), BY COUNTRY, 2020
FIGURE 22 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020
FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MEDICAL CANNABIS MARKET
FIGURE 25 GLOBAL MEDICAL CANNABIS MARKET: COMPETITIVE LANDSCAPE
FIGURE 26 CANOPY GROWTH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 CANOPY GROWTH CORPORATION: SWOT ANALYSIS
FIGURE 28 CANNABIS SATIVA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 CANNABIS SATIVA, INC.: SWOT ANALYSIS
FIGURE 30 GW PHARMACEUTICALS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 GW PHARMACEUTICALS PLC: SWOT ANALYSIS
FIGURE 32 EMERALD HEALTH THERAPEUTICS: SWOT ANALYSIS
FIGURE 33 TILRAY, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 TILRAY, INC.: SWOT ANALYSIS
FIGURE 35 AURORA CANNABIS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 AURORA CANNABIS INC.: SWOT ANALYSIS
FIGURE 37 CARA THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 CARA THERAPEUTICS: SWOT ANALYSIS
FIGURE 39 MEDICAL MARIJUANA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 MEDICAL MARIJUANA, INC.: SWOT ANALYSIS
FIGURE 41 GB SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 GB SCIENCES, INC.: SWOT ANALYSIS
FIGURE 43 CANNDOC: SWOT ANALYSIS
